SiRNAs conjugated with aromatic compounds induce RISC-mediated antisense strand selection and strong gene-silencing activity
- PMID: 22982308
- DOI: 10.1016/j.bbrc.2012.08.128
SiRNAs conjugated with aromatic compounds induce RISC-mediated antisense strand selection and strong gene-silencing activity
Abstract
Short interference RNA (siRNA) is a powerful tool for suppressing gene expression in mammalian cells. In this study, we focused on the development of siRNAs conjugated with aromatic compounds in order to improve the potency of RNAi and thus to overcome several problems with siRNAs, such as cellular delivery and nuclease stability. The siRNAs conjugated with phenyl, hydroxyphenyl, naphthyl, and pyrenyl derivatives showed strong resistance to nuclease degradation, and were thermodynamically stable compared with unmodified siRNA. A high level of membrane permeability in HeLa cells was also observed. Moreover, these siRNAs exhibited enhanced RNAi efficacy, which exceeded that of locked nucleic acid (LNA)-modified siRNAs, against exogenous Renilla luciferase in HeLa cells. In particular, abundant cytoplasmic localization and strong gene-silencing efficacy were found in the siRNAs conjugated with phenyl and hydroxyphenyl derivatives. The novel siRNAs conjugated with aromatic compounds are promising candidates for a new generation of modified siRNAs that can solve many of the problems associated with RNAi technology.
Copyright © 2012 Elsevier Inc. All rights reserved.
Similar articles
-
Palmitic acid-conjugated 21-nucleotide siRNA enhances gene-silencing activity.Mol Pharm. 2011 Dec 5;8(6):2193-203. doi: 10.1021/mp200250f. Epub 2011 Oct 24. Mol Pharm. 2011. PMID: 21985606
-
Amino-modified and lipid-conjugated dicer-substrate siRNA enhances RNAi efficacy.Bioconjug Chem. 2012 Feb 15;23(2):164-73. doi: 10.1021/bc200333w. Epub 2012 Jan 26. Bioconjug Chem. 2012. PMID: 22236254
-
Competition potency of siRNA is specified by the 5'-half sequence of the guide strand.Biochem Biophys Res Commun. 2008 Feb 29;367(1):78-83. doi: 10.1016/j.bbrc.2007.12.099. Epub 2007 Dec 27. Biochem Biophys Res Commun. 2008. PMID: 18164261
-
Exploring chemical modifications for siRNA therapeutics: a structural and functional outlook.ChemMedChem. 2010 Mar 1;5(3):328-49. doi: 10.1002/cmdc.200900444. ChemMedChem. 2010. PMID: 20043313 Review.
-
Gene silencing through RNA interference (RNAi) in vivo: strategies based on the direct application of siRNAs.J Biotechnol. 2006 Jun 25;124(1):12-25. doi: 10.1016/j.jbiotec.2005.12.003. Epub 2006 Jan 18. J Biotechnol. 2006. PMID: 16413079 Review.
Cited by
-
2'-OMe-phosphorodithioate-modified siRNAs show increased loading into the RISC complex and enhanced anti-tumour activity.Nat Commun. 2014 Mar 12;5:3459. doi: 10.1038/ncomms4459. Nat Commun. 2014. PMID: 24619206 Free PMC article.
-
Therapeutic potential of chemically modified siRNA: Recent trends.Chem Biol Drug Des. 2017 Nov;90(5):665-678. doi: 10.1111/cbdd.12993. Epub 2017 May 16. Chem Biol Drug Des. 2017. PMID: 28378934 Free PMC article. Review.
-
Gene Therapy Intervention in Neovascular Eye Disease: A Recent Update.Mol Ther. 2020 Oct 7;28(10):2120-2138. doi: 10.1016/j.ymthe.2020.06.029. Epub 2020 Jun 30. Mol Ther. 2020. PMID: 32649860 Free PMC article. Review.
-
Paving the Road for RNA Therapeutics.Trends Pharmacol Sci. 2020 Oct;41(10):755-775. doi: 10.1016/j.tips.2020.08.004. Epub 2020 Sep 3. Trends Pharmacol Sci. 2020. PMID: 32893005 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources